Author: Ethan Lewis

–News Direct– Trident Royalties PLC (AIM:TRR, OTCQX:TDTRF) CEO Adam Davidson joined Proactive's Stephen Gunnion with details of the company's performance for the quarter ended 31 March 2024. Royalty income approached amounted to US$2.98 million, with a notable performance from its gold offtake portfolio, especially during March which continued into the second quarter due to favourable gold prices. Davidson highlighted seasonal production variations, with reduced outputs in the first quarter generally compensated by higher gold prices. Significant developments include the full acquisition of Greenstone mine by Equinox Gold, anticipated to produce up to 400,000oz annually for the first five years, and Trident's gold offtake from this mine is expected to contribute s...

–News Direct– Aclara Resources Inc (TSX:ARA, OTC:ARAAF) chief operating officer Barry Murphy joined Proactive's Stephen Gunnion with news that the company has contracted global multidisciplinary consultancy firm Hatch to complete the prefeasibility study (PFS) for the Carina Module rare earths project in Brazil. Murphy cited Hatch's extensive experience and good fit with Aclara's team as the primary reasons for the choice. The pre-feasibility study, a crucial step following the issuance of a preliminary economic assessment earlier this year, will focus on various trade-offs concerning the availability of resources like power and water. The study is expected to conclude around mid-next year, after which Aclara plans to transition to a feasibility study. The pre-fea...

–News Direct– By Austin DeNoce, Benzinga The cryptocurrency market has been a rollercoaster of innovation and growth, but it's not without its share of pitfalls. National Futures Association (NFA), the self-regulatory organization for the U.S. derivatives industry, does not have regulatory oversight of the spot virtual currency. This lack of regulation for many crypto exchanges has led to significant risks for investors, including the insolvency of major platforms often resulting in frozen or lost funds. This situation is akin to the shock of finding one's bank account locked, yet it stems from insufficient oversight indirectly permitting risky operational practices that can lead to liquidity crises or shutdowns on the basis of regulatory non-compliance. Advantages Of Fu...

–News Direct– RC365 Holding PLC (LSE:RCGH) has made significant progress in 2024, according to CEO Michael Law, in an interview with Proactive's Stephen Gunnion. The company has transitioned 100% of its office operations, including finance, IT, and customer service, to Malaysia and Indonesia, hiring over ten new staff members in the region. RC365 has also won substantial contracts in Japan and secured a 100,000 grant from the Hong Kong Trade and Industry Department to further expand operations in Malaysia. Furthermore, RC365 agreed to 4 million in loan notes to fund upgrades and enhance its platform, focusing on services like virtual banking. The company's presence in Japan has particularly grown with a contract worth 600,000 aimed at integrating their services into local...

–News Direct– Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) chief legal officer John McEvoy joins Proactive's Stephen Gunnion with news that POLB 001's Immuno-modulator II has received the fully granted patent from the US Patent Office. McEvoy explained the patent encompasses a class of drugs for treating and preventing hypercytokinemia (cytokine storms) in patients triggered by an immune response, applicable across multiple disease indications. The granted patent further solidifies Poolbeg Pharma's robust intellectual property portfolio for POLB 001, potentially increasing the asset's value and making it more attractive to potential partners. McEvoy highlighted the company's ongoing efforts to strengthen and expand their IP portfolio, noting existing...

–News Direct– Faron Pharmaceuticals Limited (AIM:FARN) new CEO Dr Juho Jalkanen joined Proactive's Stephen Gunnion with his vision for the company. The founding member and former chief operating officer of Faron said one of his priorities is to meet with the US Food & Drug Administration earlier than planned in the hope of fast-tracking its lead drug, bexmarilimab, which has shown huge promise in treating a type of rare blood cancer. The move follows promising data from the phase I trials involving patients with myelodysplastic syndrome (MDS) who were unresponsive to a class of drugs called hypomethylating agents (HMAs). Jalkanen highlighted the company's ongoing phase 2 trial targeting relapsed refractory MDS, emphasising the strategic goal of securing non-diluti...

–News Direct– Iofina PLC (AIM:IOF, OTC:IOFNF) CEO Dr Tom Becker takes Proactive's Stephen Gunnion through the company's 2023 full-year performance, which marked another record. Iofina achieved its first-ever revenue exceeding $50 million, marking the sixth consecutive year of growth, a roughly 18% increase from the previous year, with EBITDA at $10.8 million. Becker attributed the growth to effective company strategies but noted challenges like increased input costs due to rising prices of chemicals used in their iodine extraction processes. He anticipates these costs will not escalate as sharply moving forward. Despite a slightly lower realised iodine price in 2023 compared to 2022, the market remains strong, particularly driven by demand for X-ray contrast media. Becker...

–News Direct– Electric Guitar PLC (AIM:ELEG) CEO John Regan spoke to Proactive's Stephen Gunnion following the company's listing on London's AIM market following the reverse takeover of 3radical. Regan emphasized Electric Guitar's "buy and build" strategy, which involves acquiring complementary businesses to enhance their market position. Despite the challenging market conditions, the company managed to complete its IPO on AIM, a testament to its team's strength and compelling business proposition. 3radical specialises in collecting first-party dataa valuable asset in today's privacy-focused advertising market. This acquisition marks Electric Guitar's entry into the technical side of the advertising industry, respond...

–News Direct– ANGLE PLC chief executive Andrew Newland joins Proactive's Stephen Gunnion with details of a supplier agreement with AstraZeneca PLC to develop an androgen receptor (AR) detection assay to enhance prostate cancer studies. With a contract value of 550,000, the project is scheduled for completion in the first quarter of next year. Newland said the agreement is an extension of a prior arrangement to develop a methodology for detecting CTC micronuclei and will use ANGLE's innovative Parsortix system. Successful development of this AR assay is expected to bolster the use of the Parsortix system in clinical oncology, particularly for assessing the efficacy of prostate cancer therapies. The discussion also touched upon the potential benefits of this development fo...

–News Direct– HIVE Digital Technologies (TSX-V:HIVE, NASDAQ:HIVE) president and CEO Aydin Kilic joined Stephen Gunnion in Proactive's London studio with insights into the companys transition and growth. Initially established as the first publicly traded crypto mining company in 2017, HIVE began by mining Ethereum in Iceland before expanding to Sweden and Canada. Following Ethereum's transition during the merge, HIVE pivoted its GPU resources from Ethereum to Bitcoin mining and later to AI computing. This strategic shift has proven profitable, with the AI computing segment achieving a $1 million annual run rate in its initial beta test phase and growing to an almost $10 million Internal Rate of Return (IRR) in the subsequent year. Kilic also discussed the operational diffe...